Published in Obstet Gynecol Sci on March 16, 2015
Frequency of Endometrial Cancer Precursors Associated With Lynch Syndrome | NCT05257057
Cancer statistics, 2013. CA Cancer J Clin (2013) 84.72
Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst (2004) 14.97
The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell (1993) 13.54
New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology (1999) 11.94
Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell (1993) 9.93
Mutation of a mutL homolog in hereditary colon cancer. Science (1994) 9.04
Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature (1994) 8.04
Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome. N Engl J Med (2006) 5.70
Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients. Nat Med (1996) 4.87
Diagnostic microsatellite instability: definition and correlation with mismatch repair protein expression. Cancer Res (1997) 4.61
Altered expression of hMSH2 and hMLH1 in tumors with microsatellite instability and genetic alterations in mismatch repair genes. Cancer Res (1996) 2.89
Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part I. The utility of immunohistochemistry. J Mol Diagn (2008) 2.30
Genetic instability of microsatellites in endometrial carcinoma. Cancer Res (1993) 2.20
Theories of endometrial carcinogenesis: a multidisciplinary approach. Mod Pathol (2000) 2.16
Immunohistochemistry for hMLH1 and hMSH2: a practical test for DNA mismatch repair-deficient tumors. Am J Surg Pathol (1999) 1.85
A population-based study of endometrial cancer and familial risk in younger women. Cancer and Steroid Hormone Study Group. Cancer Epidemiol Biomarkers Prev (1996) 1.70
Endometrial cancer and Lynch syndrome: clinical and pathologic considerations. Cancer Control (2009) 1.66
Prediction of cancer incidence and mortality in Korea, 2013. Cancer Res Treat (2013) 1.61
Expression of the human mismatch repair gene hMSH2 in normal and neoplastic tissues. Cancer Res (1996) 1.49
Absolute risk of endometrial carcinoma during 20-year follow-up among women with endometrial hyperplasia. J Clin Oncol (2010) 1.37
Heterozygous mutations in PMS2 cause hereditary nonpolyposis colorectal carcinoma (Lynch syndrome). Gastroenterology (2006) 1.34
Hormonal interactions in endometrial cancer. Endocr Relat Cancer (2000) 1.20
Current and emerging trends in Lynch syndrome identification in women with endometrial cancer. Gynecol Oncol (2009) 1.19
Lynch syndrome-associated neoplasms: a discussion on histopathology and immunohistochemistry. Fam Cancer (2013) 1.03
Testing for defective DNA mismatch repair in colorectal carcinoma: a practical guide. Arch Pathol Lab Med (2005) 0.89
Lynch syndrome presenting as endometrial cancer. Clin Chem (2013) 0.87
A Case of Perimenopausal Endometrial Cancer in a Woman with MSH2 Germline Mutation. J Menopausal Med (2013) 1.06
Hereditary risk evaluation for borderline ovarian tumors based on immunohistochemistry. J Menopausal Med (2014) 0.99
Endometrial cancer occurence five years after breast cancer in BRCA2 mutation patient. Obstet Gynecol Sci (2015) 0.95
Proton pump inhibitors enhance the effects of cytotoxic agents in chemoresistant epithelial ovarian carcinoma. Oncotarget (2015) 0.77